CXCL8 and lymphedema: Future studies are warranted to replicate our observation that differences in IL1-α, IL-6, IL-8, and VEGF levels and lymphedema symptoms and to evaluate levels of these biomarkers in relation to lymphedema symptom classes and arm lymphedema in an independent sample.